uniQure N.V. Deferred Income Tax Expense (Benefit)
uniQure N.V. (QURE) reported Deferred Income Tax Expense (Benefit) of $500.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-05-05
- uniQure N.V. deferred income tax expense (benefit) for the quarter ending 2026-03-31 was $500.00K, a 0.00% change year-over-year.
- uniQure N.V. deferred income tax expense (benefit) for the quarter ending 2025-12-31 was -$391.00K, a 144.89% decline year-over-year.
- uniQure N.V. deferred income tax expense (benefit) for the quarter ending 2025-09-30 was $1.10M.
- uniQure N.V. deferred income tax expense (benefit) for the quarter ending 2025-03-31 was $500.00K.
- uniQure N.V. deferred income tax expense (benefit) for fiscal 2025 was $1.59M, a 30.47% decline from fiscal 2024.
- uniQure N.V. deferred income tax expense (benefit) for fiscal 2024 was $2.28M, a 26.12% increase from fiscal 2023.
- uniQure N.V. deferred income tax expense (benefit) for fiscal 2023 was $1.81M.
- uniQure N.V. deferred income tax expense (benefit) for fiscal 2022 was -$1.49M, a 146.54% decline from fiscal 2021.
| Period end | Deferred Income Tax Expense (Benefit) 2 month | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 6 month as first filed | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | $500.00K 10-Q · filed 2026-05-05 | $109.00K derived: sum of 2 quarters · filed 2026-05-05 | $1.21M derived: sum of 3 quarters · filed 2026-05-05 | ||||
| 2025-12-31 | -$391.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $714.00K derived: sum of 2 quarters · filed 2026-03-02 | $1.59M 10-K · filed 2026-03-02 | ||||
| 2025-09-30 | $1.10M 10-Q · filed 2025-11-10 | $1.98M 10-Q · filed 2025-11-10 | |||||
| 2025-03-31 | $500.00K 10-Q · filed 2026-05-05 | $1.37M derived: sum of 2 quarters · filed 2026-05-05 | $1.25M derived: sum of 3 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $871.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $751.00K derived: sum of 2 quarters · filed 2026-03-02 | $2.28M 10-K · filed 2026-03-02 | ||||
| 2024-09-30 | -$120.00K 10-Q · filed 2025-11-10 | $1.41M 10-Q · filed 2025-11-10 | |||||
| 2023-12-31 | $2.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $2.85M derived: sum of 2 quarters · filed 2026-03-02 | $3.02M derived: sum of 3 quarters · filed 2026-03-02 | $1.81M 10-K · filed 2026-03-02 | |||
| 2023-09-30 | -$69.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $94.00K derived: sum of 2 quarters · filed 2023-11-07 | -$1.11M 10-Q · filed 2023-11-07 | -$1.34M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-06-30 | $163.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | -$1.04M 10-Q · filed 2023-08-01 | -$1.27M derived: sum of 3 quarters · filed 2025-02-27 | -$1.60M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-03-31 | -$1.21M 10-Q · filed 2023-05-09 | -$1.44M derived: sum of 2 quarters · filed 2025-02-27 | -$1.77M derived: sum of 3 quarters · filed 2025-02-27 | -$2.08M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | -$231.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$560.00K derived: sum of 2 quarters · filed 2025-02-27 | -$878.00K derived: sum of 3 quarters · filed 2025-02-27 | -$1.49M 10-K · filed 2025-02-27 | |||
| 2022-09-30 | -$329.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$647.00K derived: sum of 2 quarters · filed 2023-11-07 | -$1.26M 10-Q · filed 2023-11-07 | -$1.61M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-06-30 | -$318.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | -$934.00K 10-Q · filed 2023-08-01 | -$1.28M derived: sum of 3 quarters · filed 2024-02-28 | -$1.20M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-03-31 | -$616.00K 10-Q · filed 2023-05-09 | -$966.00K derived: sum of 2 quarters · filed 2024-02-28 | -$877.00K derived: sum of 3 quarters · filed 2024-02-28 | -$677.00K derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2021-12-31 | -$350.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$261.00K derived: sum of 2 quarters · filed 2024-02-28 | -$61.00K derived: sum of 3 quarters · filed 2024-02-28 | $3.21M 10-K · filed 2024-02-28 | |||
| 2021-09-30 | $200.00K 10-Q · filed 2021-10-25 | $89.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $289.00K derived: sum of 2 quarters · filed 2022-11-02 | $3.56M 10-Q · filed 2022-11-02 | |||
| 2021-06-30 | $200.00K 10-Q · filed 2021-07-26 | $3.47M 10-Q · filed 2022-08-08 | $500.00K 10-Q · filed 2021-07-26 | ||||
| 2021-03-31 | $213.00K 10-Q · filed 2022-05-02 | ||||||
| 2020-12-31 | -$16.42M 10-K · filed 2023-02-27 | ||||||
| 2020-06-30 | $0.00 10-Q · filed 2021-07-26 | $0.00 10-Q · filed 2021-07-26 | |||||
| 2018-12-31 | -$28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$60.00K derived: sum of 2 quarters · filed 2021-03-01 | $301.00K derived: sum of 3 quarters · filed 2021-03-01 | $209.00K 10-K · filed 2021-03-01 | $231.00K 10-K · filed 2019-02-28 | ||
| 2018-09-30 | -$32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-28 | $329.00K derived: sum of 2 quarters · filed 2019-10-28 | $237.00K 10-Q · filed 2019-10-28 | ||||
| 2018-06-30 | $361.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | $269.00K 10-Q · filed 2019-07-29 | |||||
| 2018-03-31 | -$92.00K 10-Q · filed 2019-04-29 | ||||||
| 2017-12-31 | -$209.00K 10-K · filed 2020-03-02 | $209.00K 10-K · filed 2018-03-14 | |||||
| 2016-12-31 | $744.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $921.00K derived: sum of 2 quarters · filed 2019-02-28 | $588.00K derived: sum of 3 quarters · filed 2019-02-28 | $1.15M 10-K · filed 2019-02-28 | |||
| 2016-09-30 | $177.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | -$156.00K derived: sum of 2 quarters · filed 2017-11-01 | $401.00K 10-Q · filed 2017-11-01 | ||||
| 2016-06-30 | -$333.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $224.00K 10-Q · filed 2017-08-08 | |||||
| 2016-03-31 | $557.00K 10-Q · filed 2017-05-09 | ||||||
| 2015-12-31 | -$1.18M 10-K · filed 2018-03-14 | ||||||
| 2014-12-31 | -$535.00K 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |